Researchers demonstrated that inhibiting GSK3α supports self-renewal and preserves stem cell identity in embryonic stem cells and epiblast stem cells, and this effect extends to neural and formative stem cells, suggesting a common checkpoint across states.

The mechanism is conserved across species, working in rats, rabbits, bovines, and humans, highlighting its fundamental role in regulating stem cells.

Overall, the study reframes stem cell biology by positioning GSK3α as a universal molecular node that governs stemness across states and species, with implications for culture techniques, aging research, and regenerative therapies.

Key contributors include Qi-Long Ying of USC’s Keck School of Medicine, with collaborative work from NIEHS.

Researchers include Duo Wang (USC) and Xiukun Wang (NIEHS), with co-authors from USC, NIEHS, Creighton University, and the University of Michigan Medical School, led by Ying and Hu.

Qi-Long Ying, a professor at USC, contributed to the study and commented on the significance of universal checkpoints.

Funding came from NIH grants (NIEHS) and private foundations, with a provisional patent filed on GSK3α targeting strategies to translate findings toward clinical applications.

Additional funding came from NIH grants R01GM129305, R01GM151373, the NIH NIEHS Intramural Research Program (Z01ES102745), plus other foundations.

The work shifts the view to a core set of checkpoints that govern stem cell identity across development, which could improve laboratory culture conditions, regenerative medicine, disease modeling, drug testing, and aging research.

The team included researchers from USC, NIEHS, Creighton University, and the University of Michigan Medical School, employing advanced methods to dissect signaling pathways and state transitions in stem cells.

The findings point to broad applications in regenerative medicine, disease modeling, and cancer research by offering a unified perspective on stem cell regulation across development and species.

Published in Cell Research on April 9, 2026, the study builds on the concept of a 'ground state' for embryonic stem cell self-renewal and proposes a framework where a common checkpoint preserves stem cell state across lineages.